Replies to post #77426 on PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

Like most, I would like to of heard that there was more progression on the diabetes and ascites front.

But then again, I understand those areas still continue to need more time in there developments.

I hate that the Italian company screwed up our process with the auditing. However, I am now crystal clear on how we got to Eurofins.